# Rab 32 Gene Polymorphisms as a Prognostic Factor in Leprosy Patients

> **NCT06819449** · NA · RECRUITING · sponsor: **South Valley University** · enrollment: 50 (estimated)

## Conditions studied

- Leprosy
- Mycobacterium Leprae Infection

## Interventions

- **DRUG:** Dapsone

## Key facts

- **NCT ID:** NCT06819449
- **Lead sponsor:** South Valley University
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2024-12-20
- **Primary completion:** 2025-12-10
- **Final completion:** 2025-12-20
- **Target enrollment:** 50 (ESTIMATED)
- **Last updated:** 2025-02-11


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06819449

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06819449, "Rab 32 Gene Polymorphisms as a Prognostic Factor in Leprosy Patients". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT06819449. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*